
-
Stocks, gold steady amid political upheaval
-
'Veggie burgers' face grilling in EU parliament
-
Trio wins physics Nobel for quantum mechanical tunnelling
-
Two years after Hamas attack, Israelis mourn at Nova massacre site
-
German factory orders drop in new blow to Merz
-
Man City star Stones considered retiring after injury woes
-
Kane could extend Bayern stay as interest in Premier League cools
-
Renewables overtake coal but growth slows: reports
-
OpenAI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Extreme rains hit India's premier Darjeeling tea estates
-
Raducanu retires from opening match in Wuhan heat with dizziness
-
UK's Starmer condemns pro-Palestinian protests on Oct 7 anniversary
-
Tokyo stocks hit new record as markets extend global rally
-
Japan's Takaichi eyes expanding coalition, reports say
-
Canadian PM to visit White House to talk tariffs
-
Indonesia school collapse toll hits 67 as search ends
-
Dodgers hold off Phillies, Brewers on the brink
-
Lawrence sparks Jaguars over Chiefs in NFL thriller
-
EU channels Trump with tariffs to shield steel sector
-
Labuschagne out as Renshaw returns to Australia squad for India ODIs
-
Open AI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Tokyo stocks hit new record as Asian markets extend global rally
-
Computer advances and 'invisibility cloak' vie for physics Nobel
-
Nobel literature buzz tips Swiss postmodernist, Australians for prize
-
Dodgers hold off Phillies to win MLB playoff thriller
-
China exiles in Thailand lose hope, fearing Beijing's long reach
-
Israel marks October 7 anniversary as talks held to end Gaza war
-
Indians lead drop in US university visas
-
Colombia's armed groups 'expanding,' warns watchdog
-
Shhhh! California bans noisy TV commercials
-
Greene Concepts Calls for Action on U.S. Water Insecurity Highlighted by L.A. Times
-
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance
-
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
-
Capstone Accelerates Path to $100M Run-Rate; Signs LOI to Acquire $15M Stone Distributor-Immediately Accretive
-
Intrusion Inc. Launches Shield Cloud Availability in AWS Marketplace
-
Nextech3D.ai Expands Blockchain Ticketing Strategy With Acquisition of EventToken.com, EventDrop.io, and NextechTickets.com, Raises $595,000
-
E-Cite Motors Eliminates Additional 671,000 Shares Through Debt Reduction, Continuing Aggressive Efforts to Minimize Dilution and Build Shareholder Value
-
McFarlane Issues NI 43-101 Mineral Resource Estimate on Its Juby Gold Project
-
Desert Oasis Healthcare Recognizes American Pharmacists Month
-
EMCORE Reintroduces the Industry-Favorite DSP-1750 Fiber Optic Gyroscope with Next-Generation Performance and Design
-
Ur-Energy Participates in TD Cowen's 10th Annual Nuclear Fuel Cycle and Next Generation Nuclear Roundtable
-
The 7 Virtues Launches Buttercream Haze, The Rebel Gourmand
-
Las Vegas, Are You Ready for the Hoedown of the Year?
-
Star Copper Phase 2 Drilling Continues to De-Risk and Expand Footprint to West and North at Star Main System
-
Sales of Licensed Branded Consumer Products Grow 3.4% to Reach $79.3 Billion in Europe, Outpacing Inflation
-
Tocvan Announces Initial Findings From Drone Magnetic Survey At Gran Pilar Gold-Silver Project: Discovery Of Structural Complex In South Block Aligns With Permitted Drill Targets
-
LIRG(TM) Appoints Kurt Dinkelacker as Chief Financial Officer
-
HotelRunner and Visa Partner Globally to Power Embedded and Autonomous Finance in Travel
-
IXOPAY Acquires Congrify, Bringing AI-Powered Insights to Global Payment Orchestration, Tokenization and Compliance
-
Trump 'happy' to work with Democrats on health care, if shutdown ends

Musk clashes with Altman after accusing App Store of favoring OpenAI
Elon Musk has accused Apple of unfairly favoring ChatGPT on its App Store and threatened legal action, triggering a fiery exchange with OpenAI CEO Sam Altman on Tuesday.
"Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in the App Store, which is an unequivocal antitrust violation," Musk said in a post on his social media network X on Monday, without providing evidence to back his claim.
"xAI will take immediate legal action," he said, referring to his own artificial intelligence company.
X users responded by pointing out that China's DeepSeek AI hit the top spot in the App Store early this year, and Perplexity AI recently ranked number one in the App Store in India.
DeepSeek and Perplexity compete with OpenAI and Musk's startup xAI.
OpenAI CEO Sam Altman called the accusation "remarkable" in a response on X on Tuesday, adding that Musk was alleged to "manipulate X to benefit himself and his own companies and harm his competitors and people he doesn't like."
Musk then called Altman a "liar" in a heated exchange, prompting the OpenAI boss to ask whether Musk would sign a sworn legal statement declaring that he had never ordered changes to the X algorithm to harm competitors or help his own companies.
OpenAI and xAI both released new versions of their AI assistants, ChatGPT and Grok, in the past week.
App Store rankings listed ChatGPT as the top free iPhone app on Tuesday, with Grok in fifth place.
Apple did not respond immediately to a request for comment.
Factors going into App Store rankings include user engagement, reviews and the number of downloads.
- AI wars -
OpenAI and Apple announced an alliance in June last year to enhance iPhones and other devices with ChatGPT features.
ChatGPT-5 rolled out free to the nearly 700 million people who use it weekly, OpenAI said in a briefing with journalists last week.
Tech industry rivals Amazon, Google, Meta, Microsoft and xAI have been pouring billions of dollars into artificial intelligence since the blockbuster launch of the first version of ChatGPT in late 2022.
Chinese startup DeepSeek shook up the AI sector early this year with a model that delivers high performance using less costly chips.
OpenAI filed counterclaims against multi-billionaire Musk in April, accusing its former co-founder of waging a "relentless campaign" to damage the organization after it achieved success without him.
OpenAI alleged in legal documents filed at the time in the northern California federal court that Musk became hostile toward the company after abandoning it years before its breakthrough achievements with ChatGPT.
The lawsuit was another round in a bitter feud between the generative AI (genAI) start-up and the world's richest person, who accused OpenAI of betraying its founding mission in a lawsuit last year.
OpenAI alleged in its countersuit that Musk "made it his project to take down OpenAI, and to build a direct competitor that would seize the technological lead -- not for humanity but for Elon Musk."
Musk founded his own genAI startup, xAI, in 2023 to compete with OpenAI and the other major AI players.
P.Silva--AMWN